Literature DB >> 30033825

Physician-Modified Fenestrated Endografts for Managing the Ruptured or Symptomatic Aortic Aneurysm: Technique Overview and Clinical Outcomes.

Aminder Singh1, Sebastian Mafeld1, Robin Williams1, James McCaslin1.   

Abstract

PURPOSE: : Fenestrated endovascular aneurysm repair (FEVAR) grafts have a 10- to 12-week manufacturing time and are generally not available for emergency cases of symptomatic or ruptured aortic aneurysm. In the absence of other alternatives, conventional off-the-shelf stent grafts can be modified by trained operators to treat these complex cases. The aim of this study is to present a single-center experience of physician-modified FEVAR.
METHODS: : A retrospective review was performed of all physician-modified FEVAR identified from the hospital endovascular database at a single tertiary referral center between September 1996 and September 2017.
RESULTS: : Eight cases of urgent or emergency endovascular aneurysm repair (EVAR) with physician-modified grafts were identified. Mean follow-up was 44 weeks (range: 5-106 weeks). Outcomes for all implanted grafts (7/8 cases) included 100% technical success, 14% rate of endoleak, no procedure-related complications, no adverse visceral events, 0% 30-day mortality and 100% 1-year target vessel patency, and freedom from aneurysm-related death. There was a 14% (1/7 cases) per patient reintervention rate.
CONCLUSION: : Modifying EVAR grafts is a highly technical process requiring meticulous planning and extensive elective experience with FEVAR. The current series demonstrates that physician modification of endografts for urgent or emergency abdominal aortic aneurysm repair is feasible and a safe alternative to open surgical aneurysm repair.

Entities:  

Keywords:  physician-modified fenestrated endovascular aneurysm repair

Mesh:

Year:  2018        PMID: 30033825     DOI: 10.1177/1538574418789023

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  3 in total

1.  Treatment of Visceral Transplant Pseudoaneurysms Using Physician-Modified Fenestrated Stent Grafts: Initial Experience.

Authors:  Sebastian Mafeld; Jennifer A Logue; Steven Masson; Rohan Thakkar; Aimen Amer; Colin Wilson; Gorab Sen; Derek Manas; Steven White; Robin Williams
Journal:  Cardiovasc Intervent Radiol       Date:  2019-02-06       Impact factor: 2.740

2.  Treatment of Stanford type A aortic dissection with triple pre-fenestration, reduced diameter, and three-dimensional-printing techniques: A case report.

Authors:  Ming Zhang; Yuan-Hao Tong; Chen Liu; Xiao-Qiang Li; Chang-Jian Liu; Zhao Liu
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

3.  Abdominal Aortic Aneurysm: Can the Anaconda™ Custom-Made Device Deliver? An International Perspective.

Authors:  Matti Jubouri; Abedalaziz O Surkhi; Sven Z C P Tan; Damian M Bailey; Ian M Williams; Mohamad Bashir
Journal:  Front Cardiovasc Med       Date:  2022-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.